Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-577958
Filing Date
2016-05-04
Accepted
2016-05-04 17:23:11
Documents
3
Period of Report
2016-06-30
Effectiveness Date
2016-05-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A d113014ddef14a.htm DEF 14A 283248
2 GRAPHIC g113014g44j17.jpg GRAPHIC 25868
3 GRAPHIC g113014g96e02.jpg GRAPHIC 21173
  Complete submission text file 0001193125-16-577958.txt   349385
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36510 | Film No.: 161620613
SIC: 2834 Pharmaceutical Preparations